Subtitle: The importance of GPs for our Brintellix strategy with Madeleine Weinert, Senior Global Brand Manager for Brintellix at Lundbeck and on the ground experience from affiliates in the French and Spanish Regions
Description: In this episode, we're focusing on the importance of General Practitioners – or GPs – and their role in the treatment of patients with Major Depressive Disorder.
Our host for this episode, Madeleine Weinert, invites affiliates from France and Spain to talk about how we can best identify and reach the GPs with the highest potential for prescribing Brintellix, and the success they've had with optimally accelerating their GPs' journey with Brintellix in their markets.
We leave you with insightful strategies that you can apply to your own practices and market.
Special mention to our Affiliates:
- Joris Paris, Marketing Manager for Brintellix in France.
- Clara Brunetto, Project Manager for Brintellix in France.
- Oriol Montana, Product Manager for Depression at Lundbeck Iberia.
- Irene Pardo, also a Product Manager for Depression at Lundbeck Iberia.
Key Takeaways:
[0:00] START
[0:04] Introduction
[1:09] Context around General Practitioners (GPs) - what is their role and what are their prescribing habits for MDD patients?
[2:32] France affiliates intro - Clara and Joris share what opportunities GPs offer in the French market
[3:41] Spain affiliates intro - Oriol and Irene share what opportunities GPs offer in the Spanish market
[4:33] GPs are a large group - how can they be targeted effectively while being smart with how we use our resources?
[6:07] Spain affiliates share their success with segmenting GPs in their market to target them effectively
[9:31] France affiliates share their success with simple, multi-channel messaging in order to communicate with GPs
[12:40] Spain affiliates share the results they have seen in their market after implementing smart segmentation and specific messaging for each high-potential GP segment in Spain
[13:07] France affiliates share the positive effects that targeting GPs has had on their total growing market share and the number of patients who are now benefiting from Brintellix each month who wouldn't have been benefiting before
[13:51] Key takeaways from the episode - the meaningful opportunities for Brintellix with GPs; how we can use smart segmentation to target GPs with the highest potential for prescribing Brintellix; and how important it is to keep messaging for GPs simple and direct
[14:56] END
Resources:
